Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120965569A reveals double five-membered ring ligands enhancing stereoselectivity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel chiral thioether-phosphine compounds for Pd-catalyzed asymmetric allylic alkylation. Efficient synthesis, high yield, reliable supply chain for pharmaceutical intermediates.
Patent CN103755634A reveals a novel synthetic route for hyperfluorescent 9-aminoacridine derivatives, offering scalable manufacturing and superior quantum yields for display applications.
Patent CN115403593A details a novel Ni-catalyzed [3+2] cycloaddition for chiral purine oxazoles, offering high yields and scalable routes for reliable pharmaceutical intermediate suppliers.
Patent CN103497082A reveals a solvent-free Henry reaction using ethanolamine-based ionic liquids, offering high yields and catalyst reusability for reliable pharma intermediate supply chains.
Patent CN101619021A reveals a novel Fries rearrangement process yielding high-purity intermediates with drastically reduced catalyst consumption and improved operational stability.
Discover a robust Lewis acid-catalyzed method for preparing 3-allyl-3-hydroxyoxindole intermediates. Enhance supply chain reliability and reduce manufacturing costs.
Novel patent CN113683574B enables high-purity synthesis for HBV intermediates with optimized supply chain reliability and cost efficiency.
Patent CN109438416B details a 4-step route to TPCA-1 using thiourea and cyclopropane derivatives, offering higher yields and milder conditions for pharmaceutical manufacturing.
Discover advanced chiral pyridoxal catalysts for asymmetric aldol reactions. Enable cost reduction in fine chemical manufacturing with scalable, metal-free synthesis routes.
Patent CN102978267B reveals advanced enzymatic glutathione production with ATP regeneration. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109384789A enables room temperature synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally. Offers green chemistry solutions.
Novel (R)-ω-transaminase mutant enables high-conversion synthesis of Sitagliptin intermediates, offering cost-effective and scalable pharmaceutical manufacturing solutions.
Patent CN107641622B reveals efficient enzymatic hydrolysis of terephthalonitrile, offering cost reduction in pharmaceutical intermediate manufacturing with high substrate tolerance.
Patent CN107384887A reveals high-purity Sitagliptin synthesis via aminotransferase. Achieves 99% ee and 76% yield, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111411094B discloses a novel mutant enzyme achieving 95.4% conversion at high substrate concentrations, offering significant cost reduction in API manufacturing.
Patent CN108866021B details a novel transaminase mutant for synthesizing sitagliptin intermediates with >99% ee. Discover cost-effective biocatalytic solutions for API manufacturing.
Novel omega-aminotransferase mutant enables high-yield sitagliptin intermediate production with 99% ee value and reduced solvent constraints for global supply chains.
Patent CN110540975B reveals high-efficiency biocatalytic route for sitagliptin precursors, offering superior stereoselectivity and reduced environmental impact for pharma supply chains.
Patent CN112707919B introduces a graphene-supported copper catalyst for synthesizing 3-decarbamoyl cefuroxime acid, offering high purity and reduced phosphorus waste.